| |
| |
|
| Insider
Information: |
Mahoney Michael F |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,696,927 |
|
|
Indirect Shares
|
196,852 |
|
|
| Direct
Value |
$127,687,731 |
|
|
|
Indirect Value
|
$14,166,200 |
|
|
| Total
Shares |
1,893,779 |
|
|
| Total
Value |
$141,853,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 1.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
Chairman, President & ... |
2024-02-18 |
1,673,878 |
2024-02-18 |
176,245 |
Premium* |
|
|
Baxter International Inc |
BAX |
Director |
2023-05-02 |
9,692 |
2023-05-02 |
20,397 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
Director |
2024-05-16 |
13,357 |
2024-05-16 |
210 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
190 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2014-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
341,669 |
884,192 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-01-01 |
4 |
D |
$13.25 |
$2,185,217 |
D/D |
(164,922) |
942,484 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
372,611 |
1,107,406 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-02-23 |
4 |
D |
$16.31 |
$3,478,923 |
D/D |
(213,300) |
1,182,049 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-02-24 |
4 |
D |
$16.62 |
$227,428 |
D/D |
(13,684) |
1,197,416 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,051 |
1,211,100 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-02-27 |
4 |
D |
$16.90 |
$456,317 |
D/D |
(27,001) |
1,227,740 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$403,927 |
D/D |
(23,901) |
1,254,583 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,325 |
1,254,741 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,744 |
1,278,484 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-08-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
52,000 |
1,336,177 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-08-01 |
4 |
AS |
$24.44 |
$1,084,994 |
D/D |
(44,400) |
1,388,177 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
452,865 |
1,395,349 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-07-01 |
4 |
AS |
$23.43 |
$2,342,570 |
D/D |
(100,000) |
1,432,577 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-11-01 |
4 |
D |
$18.28 |
$2,941,746 |
D/D |
(160,927) |
1,435,325 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-09-12 |
4 |
AS |
$53.91 |
$6,110,447 |
D/D |
(113,355) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-10-09 |
4 |
AS |
$52.09 |
$5,904,481 |
D/D |
(113,355) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-11-06 |
4 |
AS |
$52.51 |
$5,951,983 |
D/D |
(113,356) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-11-01 |
4 |
D |
$21.71 |
$3,490,013 |
D/D |
(160,756) |
1,517,091 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-06-01 |
4 |
AS |
$22.69 |
$2,268,650 |
D/D |
(100,000) |
1,532,577 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-01-01 |
4 |
D |
$57.81 |
$2,318,412 |
D/D |
(40,104) |
1,554,737 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-01-01 |
4 |
D |
$18.44 |
$2,094,028 |
D/D |
(113,559) |
1,579,039 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
95,919 |
1,594,841 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2015-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
341,669 |
1,596,252 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2017-01-01 |
4 |
D |
$21.63 |
$1,364,983 |
D/D |
(63,106) |
1,601,858 |
0 |
- |
|
190 Records found
|
|
Page 2 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
